Avalere Health

What Avalere Health does

Avalere Health is a Washington, DC-based, privately held healthcare consulting LLC founded in 2000/2001 that serves four core client segments: life sciences companies, health plans, healthcare providers, and private equity firms. The firm operates through three divisions — Advisory, Medical, and Marketing — and employs between 5,001 and 10,000 professionals under CEO Amar Urhekar.

The firm's product portfolio centers on healthcare policy and evidence-based advisory services, including the Federal Policy 360 and State Policy 360 monitoring platforms, due diligence services, market access and reimbursement advisory, health economics and outcomes research (HEOR), vaccines-focused advisory, implementation science, federal/state policy consulting, and patient-centered outcomes research. These offerings combine subscription-style policy intelligence with project-based consulting engagements, addressing regulatory, commercial, and clinical decision-making across the healthcare value chain.

Revenue is generated through professional consulting fees, advisory subscriptions (implied by the 360 product naming convention), and marketing services delivered to enterprise healthcare clients. The 20+ year operating history, multi-segment client base, and recent senior leadership hires (including Sarah Hall as President of US Marketing and Matt Kazan as SVP of Policy in late 2025) and a May 2026 partnership with Doceree on the Daily Command AI platform point to a scaling enterprise services model with growing investment in technology-enabled capabilities.

Name

Avalere Health

Legal name

Avalere Health, LLC

Website

https://avalere.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Avalere Health is a Washington, DC-based healthcare consulting firm serving life sciences companies, health plans, providers, and private equity through Advisory, Medical, and Marketing divisions spanning policy, HEOR, and market access services.

Ownership category

akta.pro rank

Product category

Healthcare Consulting

NAICS

Management, Scientific, and Technical Consulting Services (5416), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA)

Keywords

• Healthcare consulting
• Market access strategy
• Health policy advisory
• Real-world evidence
• Due diligence services

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Advisory and Consulting Services: Avalere Health generates revenue through providing strategic consulting services to life sciences companies, health plans, healthcare providers, and private equity firms. Services include federal and state policy analysis, market access and reimbursement strategy, HEOR, patient-centered outcomes research, implementation science, due diligence, and vaccines advisory.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Avalere Health Advisory provides strategic consulting and advisory services to life sciences companies, health plans, healthcare providers, and private equity firms. Core offerings include federal and state healthcare policy analysis, market access and reimbursement strategy, health economics and outcomes research (HEOR), patient-centered outcomes research, implementation science, due diligence for healthcare transactions, and vaccines advisory. The firm also offers subscription-based policy intelligence products (Federal Policy 360 and State Policy 360) that track legislative and regulatory developments.

Product overview

Avalere Health Advisory is a strategic healthcare consulting and advisory firm offering a portfolio of analytical products and specialized services. The core product offerings include Federal Policy 360 and State Policy 360, which are policy intelligence platforms providing clients with analysis on federal and state healthcare regulatory developments. These products are complemented by a suite of advisory services spanning Due Diligence, Market Access & Reimbursement, Health Economics Outcomes Research (HEOR), Vaccines, Implementation Science and Evaluation, Federal and State Policy, and Patient-Centered Outcomes. The firm serves life sciences companies, health plans, healthcare providers, and private equity clients, providing data-driven strategies and analysis across the healthcare product lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• Federal Policy 360 A policy intelligence product providing analysis and insights on federal healthcare policy developments and their implications for life sciences, health plan, and provider clients.
• State Policy 360 A policy intelligence product offering state-level healthcare policy tracking and analysis to help clients navigate regional regulatory landscapes.
• Due Diligence Services Advisory service conducting continuous, thorough analysis of acquisition targets, uncovering potential risk factors, and identifying value critical to healthcare transactions for private equity and strategic acquirers.
• Market Access & Reimbursement Advisory service helping life sciences companies successfully initiate and sustain product commercialization at each point along the access-and-commercialization continuum.
• HEOR (Health Economics Outcomes Research) Service utilizing comprehensive real-world data access to develop real-world evidence that supports data-driven decision making and market differentiation for life sciences clients.
• Vaccines Advisory Service supporting clients in generating evidence and translating it into strong recommendations, influencing the policy environment, and shaping patient-access channels for vaccines.
• Implementation Science and Evaluation Service harnessing implementation science to close the gap between evidence and practice and integrate evidence-based interventions into healthcare settings.
• Federal and State Policy Advisory Advisory service providing multistakeholder perspectives to help clients anticipate, interpret, and respond to changes in the complex legislative and regulatory environment.
• Patient-Centered Outcomes Service helping clients access and analyze information to understand patient perspectives and facilitate stakeholder conversations to gain insights on the patient experience.

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• DocereeflagshipStrategic or Co-development Partner · 7 May 2026Avalere Health participated as one of 75 senior operators from major pharmaceutical manufacturers and agencies who co-built Doceree's Daily Command platform over the previous quarter. Avalere is among five flagship beta testing partners for the platform launching in June 2026, with full industry release scheduled for July 14, 2026. The platform targets a $30 billion pharmaceutical brand team software market.

Scale indicators2 records

Recent moves3 records

Expansion highlights4 records

Direct peers

• IQVIA: Global life sciences and healthcare analytics firm with significant market access, HEOR, and policy advisory practices serving pharma, biotech, and health plans. Closely comparable to Avalere's Advisory division in service scope and target customer base.
• ZS Associates: Management consulting firm focused on healthcare and pharmaceuticals, with deep market access, pricing, and real-world evidence practices. Directly competes with Avalere in pharma strategy and evidence generation.
• Charles River Associates: Consulting firm with a Life Sciences practice spanning HEOR, market access, pricing, and policy analysis. Serves the same pharma, biotech, and device manufacturers as Avalere.
• Huron Consulting Group: Professional services firm with a Healthcare segment providing strategy, technology, and analytics consulting to providers, payors, and life sciences companies. Comparable in client base and consulting model.
• The Lewin Group: Healthcare policy and human services consulting firm owned by Optum, focused on federal and state policy analysis, program evaluation, and market research. Highly comparable in policy advisory focus to Avalere's Federal/State Policy practice.
• Mathematica: Policy research and data analytics consultancy with significant health division work in Medicare, Medicaid, and pharma policy research. Comparable in policy evaluation and HEOR-oriented engagements.
• Analysis Group: Economic and financial consulting firm with a substantial Health Care practice delivering HEOR, epidemiology, and policy economics research. Highly comparable in evidence generation and life sciences client base.

Broad incumbents

• McKinsey & Company (Healthcare Practice): Global management consulting firm with a large healthcare practice covering pharma, payors, providers, and policy. Competes with Avalere for premium healthcare strategy engagements at the largest enterprise clients.
• Boston Consulting Group (Healthcare Practice): Global strategy consulting firm with a Healthcare practice that overlaps Avalere in market access, pricing, and pharma strategy work, particularly with top-tier life sciences clients.
• Deloitte (Life Sciences & Healthcare Consulting): Big Four professional services firm with a large Life Sciences and Healthcare Consulting practice covering market access, policy, and HEOR. Competes with Avalere for enterprise healthcare advisory mandates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/avalere-health
• Xx.com/avalerehealth
• Facebookfacebook.com/avalerehealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avalere Health